by MASA | Mar 31, 2024 | Drug Updates
US FDA approved of XHANCE as the first and only medication for adults with chronic rhinosinusitis without nasal polyps. It is a fluticasone propionate nasal spray which uses the Exhalation Delivery System to enable topical steroid to the inflamed areas and is proven...
by MASA | Mar 11, 2024 | Allergies, Anaphylaxis, Asthma
Central Illinois School Asthma and Allergy Resources for Students Welcome to the Central Illinois School Health Resources page! This page aims to unify and provide essential information and resources for schools and school nurses to promote student health and safety...
by MASA | Feb 26, 2024 | Allergies, Food Allergies / Intolerance
(Enrollment Closed) Join Our Groundbreaking Peanut Allergy Clinical Trial for Children in Bloomington/Normal, IL We’re excited to announce our call for participants in the VITESSE (DBV) clinical trial, a new study focused on innovative treatments for peanut...
by MASA | Jan 31, 2024 | Immunodeficiency Hypogammaglobulinemia, Rare Diseases
What is PIDD? Image source and credit: https://info4pi.org/library/educational-materials/ What is PIDD? PIDD stands for Primary Immunodeficiency Diseases. These diseases are a group of more than 500 rare, chronic disorders in which part of the body’s immune...
by MASA | Jan 19, 2024 | Immune System, Immunodeficiency Hypogammaglobulinemia, News, Patient Opportunity, Rare Diseases
CIIC Annual Patient Scholarship: Empowering PIDD and Rare Disease Patients The CIIC (Coalition of Immunology and Allergy Clinics) is proud to announce the continuation of its Annual Patient Scholarship program, initiated in 2021. This unique scholarship is...
